Skip to main content
. Author manuscript; available in PMC: 2014 Dec 30.
Published in final edited form as: J Vasc Surg. 2013 Oct 17;59(2):283–290.e1. doi: 10.1016/j.jvs.2013.08.047

Fig. 6.

Fig. 6

Projected vendor market shares reflecting shift in device utilization based on cost for the 44% of the total endovascular aneurysm repair (EVAR) volume whereby devices can be used with clinical equipoise. As shown in the figure (arrows), vendor A would increase market share from 12% to 51%, whereas vendor D would decrease its market share from 54% to 30%.